Skip to contentP
Pulse Biosciences, Inc.
P
PLSEPulse Biosciences, Inc. Q1 2025 · 10-Q
Revenue$0.00$0.00— vs Q1 2024 Net Income-$16.80M-$16.80MN/M vs Q1 2024 EPS, diluted—
Operating Income-$18,044,000N/M Operating Cash Flow-$13,521,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pulse Biosciences, Inc. · CIK 1625101 · Engraved from SEC EDGAR
Free Cash Flowderived-$13,566,000N/M ended Mar 31, 2025 · filed May 8, 2025 · 38 d after period end